Doxycycline Postexposure Prophylaxis Update at Chicago Department of Public Health Sexually Transmitted Infection Specialty Clinics, 2024
Doxycycline postexposure prophylaxis has demonstrated efficacy, but its effectiveness in areas with high sexually transmitted infection (STI) rates, like Chicago, is less understood. In 2024, 219 patients prescribed doxycycline postexposure prophylaxis at Chicago STI clinics observed a 77% reduction in bacterial STI positivity, highlighting its potential for STI prevention.
Authors
- Róbert Wágner (ORCID: https://orcid.org/0000-0002-6120-0191)
- Irina Tabidze (ORCID: https://orcid.org/0000-0002-2683-7138)
- David Kern
- Casey Morgan Luc (ORCID: https://orcid.org/0000-0003-3669-9821)
- Teresa L. Rutledge
- Michael Wasz
- Nancy E. Williamson
- MSN Van Quach
Institutions
- Illinois Department of Public Health (US)
- Chicago Department of Public Health (US)
- CDC Foundation (US)
Publication Details
- Journal
- Sexually Transmitted Diseases
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1097/olq.0000000000002239
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00